| 标题 |
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study |
| 网址 | |
| DOI | |
| 其它 |
期刊:American Heart Journal 作者:Dean J. Kereiakes; Jennifer G. Robinson; Christopher P. Cannon; Christelle Lorenzato; Robert Pordy; et al 出版日期:2015-06-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)